- Cardanol-derived AChE inhibitors: Towards the development of dual binding derivatives for Alzheimer's disease2016 | Publication without faculty affiliation
- Quantitative histochemistry of cholinesterases after poisoning of AChE inhibitors +12008 | Faculty of Medicine in Hradec Králové
- Quantitative histochemistry of cholinesterases after poisoning of AChE inhibitors +12007 | First Faculty of Medicine
- Quantificative histochemistry of cholinesterases after AChE inhibitors intoxication2008 | First Faculty of Medicine
- Development of small bisquaternary cholinesterase inhibitors as drugs for pre-treatment of nerve agent poisonings2018 | Publication without faculty affiliation
- The antioxidant additive approach for Alzheimer's disease therapy: New ferulic (Lipoic) acid plus melatonin modified tacrines as Cholinesterases inhibitors, direct antioxidants, and nuclear factor (Erythroid-Derived 2)-like 2 activators2016 | Publication without faculty affiliation
- Development of 2-Methoxyhuprine as Novel Lead for Alzheimer's Disease Therapy2017 | Faculty of Pharmacy in Hradec Králové
- Preparation and in vitro testing of new acetylcholinesterase inhibitorsPublication without faculty affiliation
- Novel acetylcholinesterase reactivator - oxime K048 - reactivation activity in vitro2010 | Central Library of Charles University
- Preparation and testing of biological activity of novel acetylcholinesterase inhibitorsPublication without faculty affiliation
- Structure-activity relationship of quaternary acetylcholinesterase inhibitors - outlook for early Myasthenia gravis treatment2010 | Central Library of Charles University
- Near-complete adaptation of the PRiMA knockout to the lack of central acetylcholinesterase2012 | First Faculty of Medicine
- Reversible cholinesterase inhibitors as pretreatment for exposure to organophosphates: assessment using azinphos-methyl2015 | Publication without faculty affiliation
- Different sensitivities of rat skeletal muscles and brain to novel anti-cholinesterase agents, alkylammonium derivatives of 6-methyluracil (ADEMS)2011 | Faculty of Science
- Near-complete adaptation of the PRiMA knockout to the lack of central acetylcholinesterase2012 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- In vitro effects of acetylcholinesterase inhibitors and reactivators on Complex I of electron transport chain2011 | Faculty of Physical Education and Sport, First Faculty of Medicine
- Cholinergic properties of new 7-methoxytacrine-donepezil derivatives2015 | Faculty of Science
- Prophylactic administration of non-organophosphate cholinesterase inhibitors before acute exposure to organophosphates: assessment using terbufos sulfone2014 | Publication without faculty affiliation
- Small Quaternary Inhibitors K298 and K524: Cholinesterases Inhibition, Absorption, Brain Distribution, and Toxicity2016 | Faculty of Medicine in Hradec Králové
- In vitro functional interactions of acetylcholine esterase inhibitors and muscarinic receptor antagonists in the urinary bladder of the rat2014 | Faculty of Pharmacy in Hradec Králové
- The interaction of quaternary reversible acetylcholinesterase inhibitors with the nicotinic receptor2014 | Publication without faculty affiliation
- Design, synthesis and biological evaluation of new phthalimide and saccharin derivatives with alicyclic amines targeting cholinesterases, beta-secretase and amyloid beta aggregation2017 | Publication without faculty affiliation
- Acid dissociation constants and molecular descriptors of some xylene linked bispyridinium oximes2015 | First Faculty of Medicine
- The study of the index of ideality of correlation as a new criterion of predictive potential of QSPR/QSAR-models2019 | First Faculty of Medicine
- Pralidoxime-like reactivator with increased lipophilicity- Molecular modeling and in vitro study2023 | Publication without faculty affiliation
- Dementia with Lewy bodies2023 | Third Faculty of Medicine
- Novel tacrine/acridine anticholinesterase inhibitors with piperazine and thiourea linkers2014 | Faculty of Pharmacy in Hradec Králové
- Discovery of sustainable drugs for Alzheimer's disease: cardanol-derived cholinesterase inhibitors with antioxidant and anti-amyloid properties2021 | Publication without faculty affiliation